$CTIX Up to date company activities and other impo
Post# of 88930
$CTIX
DD Notes ~ http://www.ddnotesmaker.com/CTIX
##### recent news/filings ~ source: finance.yahoo.com
Mon, 16 Dec 2013 14:06:06 GMT ~ Cellceutix: An Undiscovered Company Set To Rise In 2014
read full: http://seekingalpha.com/article/1900321-cellc...urce=yahoo
*********************************************************
Mon, 16 Dec 2013 12:00:00 GMT ~ Cellceutix Submits Application for IRB Review to Commence Phase 2b Clinical Trial of Novel Antibiotic Brilacidin
- Cellceutix Corporation , a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, is pleased to announce that it has submitted the ...
read full: http://finance.yahoo.com/news/cellceutix-subm...00295.html
*********************************************************
Mon, 09 Dec 2013 12:00:00 GMT ~ Cellceutix Updates on Current Status of Programs
- Cellceutix Corporation , a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, today updates shareholders on recent developments ...
read full: http://finance.yahoo.com/news/cellceutix-upda...00798.html
*********************************************************
Tue, 19 Nov 2013 10:38:12 GMT ~ 3 Innovative Biotech Companies Poised To Shine At TAP Partnership Conference
- The Annual Therapeutic Area Partnerships (TAP) is the industry's "most efficient partnering meeting for biopharmaceutical companies and executives seeking to understand the strategic outlook for new ...
read full: http://seekingalpha.com/article/1848141-3-inn...urce=yahoo
*********************************************************
Mon, 18 Nov 2013 12:00:00 GMT ~ Cellceutix Identifies Drug Candidates for Gram-Negative and Candida Fungal Infections
- Cellceutix Corporation , a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, is pleased to report that it has made significant ...
read full: http://finance.yahoo.com/news/cellceutix-iden...00393.html
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=CTIX&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=CTIX&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CTIX/company-info
Ticker: $CTIX
OTC Market Place: OTCQB
CIK code: 0001355250
Company name: Cellceutix Corp.
Company website: http://www.cellceutix.com
Incorporated In: NV, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/CTIX/filings
Latest financials: http://www.otcmarkets.com/stock/CTIX/financials
Latest news: http://www.otcmarkets.com/stock/CTIX/news - http://finance.yahoo.com/q/h?s=CTIX+Headlines
Major holdings: http://data.cnbc.com/quotes/CTIX/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=CTIX+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/CTIX.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=CTIX
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Cellceutix+Corp.&a...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...eutix+Corp.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.cellceutix.com
Alexa: http://www.alexa.com/siteinfo/http://www.cellceutix.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.cellceutix.com
http://www.pennystocktweets.com/stocks/profile/CTIX
##### last known share structure ~ source: otcmarkets.com
Market Value: $194,090,983 a/o Dec 16, 2013
Shares Outstanding: 104,914,045 a/o Nov 04, 2013
Float: Not Available
Authorized Shares: 300,000,000 a/o May 12, 2008
Par Value: 0.0001
##### business description ~ source: otcmarkets.com
An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.
DD Notes ~ http://www.ddnotesmaker.com/CTIX